| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,157 |
10,973 |
$967K |
| 99199 |
Unlisted special service, procedure or report |
72,163 |
28,443 |
$398K |
| T1017 |
Targeted case management, each 15 minutes |
1,343 |
1,056 |
$347K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,439 |
1,838 |
$102K |
| 96127 |
|
7,391 |
4,353 |
$30K |
| 97803 |
|
485 |
242 |
$19K |
| 81025 |
|
2,500 |
1,765 |
$14K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
119 |
105 |
$13K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
191 |
106 |
$11K |
| 99215 |
Prolong outpt/office vis |
110 |
73 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
536 |
360 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
555 |
341 |
$6K |
| 99401 |
|
442 |
221 |
$6K |
| 99406 |
|
530 |
381 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
2,106 |
1,287 |
$3K |
| 96160 |
|
1,245 |
867 |
$3K |
| Q3014 |
Telehealth originating site facility fee |
193 |
120 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
27 |
25 |
$2K |
| 81003 |
|
570 |
368 |
$737.69 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19 |
12 |
$727.74 |
| 85018 |
|
233 |
171 |
$403.57 |
| 81002 |
|
116 |
105 |
$229.95 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
16 |
13 |
$212.28 |
| 99173 |
|
1,186 |
823 |
$193.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
12 |
$166.35 |
| 94760 |
|
438 |
341 |
$60.26 |
| 87210 |
|
61 |
14 |
$51.70 |
| 92551 |
|
970 |
667 |
$8.02 |
| 99000 |
|
5,030 |
3,347 |
$0.00 |
| 3074F |
|
2,743 |
2,187 |
$0.00 |
| 3079F |
|
445 |
388 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
358 |
288 |
$0.00 |
| 3044F |
|
495 |
388 |
$0.00 |
| 90686 |
|
72 |
48 |
$0.00 |
| 94761 |
|
95 |
56 |
$0.00 |
| 3075F |
|
24 |
24 |
$0.00 |
| 3078F |
|
2,360 |
1,895 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
290 |
244 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
149 |
89 |
$0.00 |
| 3077F |
|
105 |
88 |
$0.00 |
| 90734 |
|
16 |
12 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
53 |
19 |
$0.00 |